Trends in worldwide research on cardiac fibrosis over the period 1989–2022: a bibliometric study
Frontiers in Cardiovascular Medicine · 05.06.2023 · 10
DOI: 10.3389/fcvm.2023.1182606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 05.06.2023. Verfasst von Yukang Mao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical Unive…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Cardiac fibrosis is a hallmark of various end-stage cardiovascular diseases (CVDs) and a potent contributor to adverse cardiovascular events. During the past decades, extensive publications on this topic have emerged worldwide, while a bibliometric analysis of the current status and research trends is still lacking.
Methods
We retrieved relevant 13,446 articles on cardiac fibrosis published between 1989 and 2022 from the Web of Science Core Collection (WoSCC). Bibliometrix was used for science mapping of the literature, while VOSviewer and CiteSpace were applied to visualize co-authorship, co-citation, co-occurrence, and bibliographic coupling networks.
Results
We identified four major research trends: (1) pathophysiological mechanisms; (2) treatment strategies; (3) cardiac fibrosis and related CVDs; (4) early diagnostic methods. The most recent and important research themes such as left ventricular dysfunction, transgenic mice, and matrix metalloproteinase were generated by burst analysis of keywords. The reference with the most citations was a contemporary review summarizing the role of cardiac fibroblasts and fibrogenic molecules in promoting fibrogenesis following myocardial injury. The top 3 most influential countries were the United States, China, and Germany, while the most cited institution was Shanghai Jiao Tong University, followed by Nanjing Medical University and Capital Medical University.
Conclusions
The number and impact of global publications on cardiac fibrosis has expanded rapidly over the past 30 years. These results are in favor of paving the way for future research on the pathogenesis, diagnosis, and treatment of cardiac fibrosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.
- Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of General Practice, Clinical Research Center for General Practice, Yangpu Hospital, Tongji University School of Medicine, Shanghai, China.
- Department of Cardiology, Yangpu Hospital, Tongji University School of Medicine, Shanghai, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Mao, Y., Fu, Q., Su, F., Zhang, W., Zhang, Z., Zhou, Y., & Yang, C. (2023). Trends in worldwide research on cardiac fibrosis over the period 1989–2022: a bibliometric study. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1182606
Vancouver
Mao Y, Fu Q, Su F, Zhang W, Zhang Z, Zhou Y, et al. Trends in worldwide research on cardiac fibrosis over the period 1989–2022: a bibliometric study. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1182606
BibTeX
@article{Mao2023,
author = {Mao, Yukang and Fu, Qiangqiang and Su, Feng and Zhang, Wenjia and Zhang, Zhong and Zhou, Yimeng and Yang, Chuanxi},
title = {Trends in worldwide research on cardiac fibrosis over the period 1989–2022: a bibliometric study},
journal = {Frontiers in Cardiovascular Medicine},
year = {2023},
volume = {10},
doi = {10.3389/fcvm.2023.1182606}
}
EUVIMED